Minocycline Export Market Intelligence: India's 92 Suppliers Shipping to 34 Countries — TransData Nexus 2026

Q: Who are the top minocycline exporters from India?

The top minocycline exporters from India are: 1. AUROBINDO PHARMA LTD — $11.5M (50.5% market share); 2. AUROBINDO PHARMA LIMITED — $3.2M (14.1% market share); 3. WATSON PHARMA PRIVATE LIMITED — $2.9M (12.6% market share); 4. TORRENT PHARMACEUTICALS LTD — $1.6M (7.0% market share); 5. ZYDUS LIFESCIENCES LIMITED — $815.5K (3.6% market share). Together they account for 87.9% of India's total minocycline export value.

Q: What is the total export value of minocycline from India?

The total export value of minocycline from India is $22.8M USD, recorded across 654 shipment transactions from 92 active exporters to 34 destination countries. The average shipment value is $34.9K.

Q: Which countries import minocycline from India?

India exports minocycline to 34 countries worldwide. The top importing countries are: UNITED STATES (93.9% share, $21.4M), NETHERLANDS (2.2% share, $491.8K), BRAZIL (1.3% share, $307.2K), PERU (0.9% share, $207.7K), BELGIUM (0.7% share, $157.9K). These five markets account for 99.0% of total export value.

Q: What is the HS code for minocycline exports from India?

The primary HS code for minocycline exports from India is 30042049. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of minocycline exports from India?

The average unit price for minocycline exports from India is $21.44 USD per unit, with prices ranging from $0.07 to $641.71 depending on formulation, packaging, and order volume. The total market is valued at $22.8M across 654 shipments.

Q: Which ports handle minocycline exports from India?

The primary ports for minocycline exports from India are SAHAR AIR CARGO ACC (INBOM4) (22.9% of shipments), SAHAR AIR (22.2% of shipments), HYDERABAD ICD (7.6% of shipments), HYDERABAD ICD (INSNF6) (7.2% of shipments), DELHI AIR (5.0% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of minocycline?

India is one of the world's leading exporters of minocycline due to its large base of 92 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports minocycline to 34 countries, demonstrating 17% global market coverage.

Q: What certifications do Indian minocycline exporters need?

Indian minocycline exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import minocycline from India?

There are 131 registered buyers importing minocycline from India, spread across 34 countries. The repeat buyer rate is 59.5%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top minocycline supplier from India?

AUROBINDO PHARMA LTD is the leading minocycline exporter from India with a market share of 50.5% and total export value of $11.5M across 113 shipments. The top 5 suppliers together control 87.9% of total export value.

Suresh Sormare

Minocycline

India Pharmaceutical Trade Intelligence

$22.8M92 Suppliers34 CountriesHS 30042049

ExportsIndia → UNITED STATES93.9%India → NETHERLANDS2.2%

ImportsUNITED STATES → India$52.2K CHINA → India$2.8K

#1 Buyer: AUROLOGISTICS LLC,

Minocycline Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Minocycline to the World

Between 2022 and 2026, India exported $22.8M worth of minocycline across 654 verified shipments to 34 countries — covering 17% of world markets in the Advanced Antibiotics segment. The largest destination is UNITED STATES (93.9%). AUROBINDO PHARMA LTD leads with a 50.5% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Minocycline export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Minocycline export data snapshot — $22.8M · 92 exporters · 34 countriesTransData Nexus · Indian Customs Data

Top Minocycline Exporters from India

92 active exporters · Ranked by export value

View all 92 →

Top Minocycline Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	AUROBINDO PHARMA LTD	$11.5M	113	1	50.5%
2	AUROBINDO PHARMA LIMITED

Top Countries Importing Minocycline from India

34 destination markets · Ranked by import value

All 34 countries →

Top Countries Importing Minocycline from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$21.4M	93.9%
2	NETHERLANDS	$491.8K	2.2%
3	BRAZIL	$307.2K	1.3%
4	PERU	$207.7K	0.9%
5	BELGIUM	$157.9K	0.7%
6	SINGAPORE	$43.9K	0.2%
7	SRI LANKA	$42.3K	0.2%
8	UNITED ARAB EMIRATES	$21.9K	0.1%
9	ITALY	$21.0K	0.1%
10	MAURITIUS	$19.1K	0.1%

UNITED STATES is India's largest minocycline export destination, absorbing 93.9% of total exports worth $21.4M. The top 5 importing countries — UNITED STATES, NETHERLANDS, BRAZIL, PERU, BELGIUM — together account for 99.0% of India's total minocycline export value. The remaining 29 destination countries collectively receive the other 1.0%, indicating a focused distribution strategy targeting key markets.

Who Supplies Minocycline to India?

5 origin countries · Total import value: $57.6K

India imports minocycline from 5 countries with a combined import value of $57.6K. The largest supplier is UNITED STATES ($52.2K, 19 shipments), followed by CHINA and UNITED KINGDOM. All values are from Indian Customs (DGFT) import records.

Countries Supplying Minocycline to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED STATES	$52.2K	19	90.6%
2	CHINA	$2.8K	2	4.9%
3	UNITED KINGDOM	$1.5K	2	2.6%
4	GERMANY	$1.1K	5	1.9%
5	SOUTH AFRICA	$14	2	0.0%

UNITED STATES is the largest supplier of minocycline to India, accounting for 90.6% of total import value. The top 5 origin countries — UNITED STATES, CHINA, UNITED KINGDOM, GERMANY, SOUTH AFRICA — together supply 100.0% of India's minocycline imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Minocycline

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, minocycline is approved for various indications, including the treatment of acne and certain bacterial infections. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for minocycline, reflecting a competitive generic market. Notably, Aurobindo Pharma Ltd, the leading Indian exporter with a 50.5% share, has secured FDA approvals for its minocycline products, underscoring its significant presence in the U.S. market.

As of March 2026, there are no active FDA import alerts specifically targeting minocycline products from India. This indicates compliance with FDA standards by Indian manufacturers. However, the FDA maintains the authority to issue import alerts if products appear to violate U.S. regulations, leading to detention without physical examination. Therefore, continuous adherence to FDA guidelines is imperative for uninterrupted market access.

2EU & UK Regulatory Framework

In the European Union, minocycline requires marketing authorization from the European Medicines Agency (EMA) before it can be marketed. The EMA evaluates the quality, safety, and efficacy of medicinal products. Similarly, in the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) oversees the approval process for pharmaceuticals. Manufacturers exporting minocycline to these regions must comply with Good Manufacturing Practice (GMP) standards as outlined by the EMA and MHRA to ensure product quality and safety.

3WHO Essential Medicines & Global Standards

Minocycline is included in the World Health Organization's Model List of Essential Medicines, highlighting its importance in a basic health system. This inclusion underscores the global recognition of minocycline's therapeutic value. Additionally, minocycline formulations are standardized in various pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring consistent quality across different markets.

4India Regulatory Classification

In India, minocycline is classified under Schedule H of the Drugs and Cosmetics Rules, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines; however, as of March 2026, minocycline is not listed under the Drugs (Prices Control) Order (DPCO), allowing manufacturers to set prices based on market dynamics. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) for certain pharmaceutical products, ensuring compliance with export regulations.

5Patent & Exclusivity Status

The primary patents for minocycline have expired, leading to a robust generic market with multiple manufacturers producing the drug. This competitive landscape benefits consumers through reduced prices and increased accessibility.

6Recent Industry Developments

In June 2025, the FDA updated its import alert system to reinforce that all unauthorized e-cigarettes may be detained without physical examination. While this action does not directly impact minocycline, it reflects the FDA's ongoing efforts to regulate imported products rigorously.

In October 2025, the FDA announced the successful completion of a joint operation with U.S. Customs and Border Protection, resulting in the seizure of approximately three million units of misdeclared, unauthorized e-cigarette products. This operation underscores the importance of accurate product declaration and compliance with U.S. import regulations.

These developments highlight the critical need for Indian exporters of minocycline to maintain stringent quality control measures and ensure full compliance with international regulatory standards to facilitate seamless market access.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Minocycline

Retail & reference prices across 9 markets vs. India FOB export price of $21.44/unit

Global Price Benchmark for Minocycline across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.80	USD	According to the FDA's National Drug Code (NDC) directory, the average pharmacy acquisition cost for Minocycline 100 mg tablets is approximately $0.80 per unit as of February 2026.
United Kingdom	$0.65	GBP	The UK's NHS Drug Tariff lists Minocycline 100 mg tablets at £0.50 per unit as of March 2026.
Germany	$0.75	EUR	The German Federal Institute for Drugs and Medical Devices (BfArM) provides a reference price of €0.70 per Minocycline 100 mg tablet as of March 2026.
Australia

Supply Chain Risk Assessment — Minocycline

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, renowned as the "pharmacy of the world," heavily relies on China for Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs). Approximately 70% of India's API and KSM requirements are imported from China, creating a significant dependency. This reliance exposes the supply chain to vulnerabilities, as disruptions in Chinese production or export policies can directly impact the availability of essential drugs like Minocycline.

The COVID-19 pandemic underscored these risks when supply chain disruptions led to shortages and price hikes for various APIs. In response, the Indian government initiated the Production Linked Incentive (PLI) scheme in October 2024 to bolster domestic API and KSM manufacturing. Despite these efforts, challenges such as cost competition and infrastructure limitations persist, hindering rapid progress toward self-sufficiency.

2Supplier Concentration & Single-Source Risk

Our proprietary data indicates that the top five Indian exporters account for 87.9% of Minocycline exports, with AUROBINDO PHARMA LTD alone contributing 50.5%. This high supplier concentration poses a significant risk; any operational or regulatory issues affecting these key players could disrupt the global supply of Minocycline.

The PLI scheme aims to reduce such dependencies by encouraging diversification and enhancing domestic production capabilities. However, the effectiveness of this initiative remains to be fully realized, as the industry continues to grapple with competitive pressures from Chinese manufacturers, who have been known to implement aggressive pricing strategies to maintain market dominance.

Access Complete Minocycline Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 654 transactions across 34 markets.

Request Demo View Pricing

Frequently Asked Questions — Minocycline Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top minocycline exporters from India?

The leading minocycline exporters from India are AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED, WATSON PHARMA PRIVATE LIMITED, and 8 others. AUROBINDO PHARMA LTD leads with 50.5% market share ($11.5M). The top 5 suppliers together control 87.9% of total export value.

What is the total export value of minocycline from India?

The total export value of minocycline from India is $22.8M, recorded across 654 shipments from 92 active exporters to 34 countries. The average shipment value is $34.9K.

Which countries import minocycline from India?

India exports minocycline to 34 countries. The top importing countries are UNITED STATES (93.9%), NETHERLANDS (2.2%), BRAZIL (1.3%), PERU (0.9%), BELGIUM (0.7%), which together account for 99.0% of total export value.

What is the HS code for minocycline exports from India?

The primary HS code for minocycline exports from India is 30042049. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Minocycline

Minocycline

Top Minocycline Exporters from India

Top Countries Importing Minocycline from India

Who Supplies Minocycline to India?

Quick Facts

Related Advanced Antibiotics

Related Analysis

Need Details?

Regulatory Landscape — Minocycline

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Minocycline

Supply Chain Risk Assessment — Minocycline

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Minocycline Trade Intelligence

Frequently Asked Questions — Minocycline Exports from India

Who are the top minocycline exporters from India?

What is the total export value of minocycline from India?

Which countries import minocycline from India?

What is the HS code for minocycline exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of minocycline exports from India?

Which ports handle minocycline exports from India?

Why is India a leading exporter of minocycline?

What certifications do Indian minocycline exporters need?

How many buyers import minocycline from India?

What is the market share of the top minocycline exporter from India?

Analysis Methodology